Fox Jonathan C

Insider Reports History

Entity
Individual
Location
C/O Myokardia, Inc., 333 Allerton Avenue, South San Francisco, CA
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fox Jonathan C:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Director Common Stock 10.9K $171K $15.78 Dec 26, 2023 Direct
Edgewise Therapeutics, Inc. Director Stock Option (Right to Buy) 20.6K Jun 10, 2024 Direct

Insider Reports Filed by Fox Jonathan C

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 12, 2024 Director
EWTX Edgewise Therapeutics, Inc. Dec 26, 2023 1 $101K 4 Dec 28, 2023 Director
EWTX Edgewise Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
EWTX Edgewise Therapeutics, Inc. Mar 3, 2023 1 $0 4 Mar 7, 2023 Director
EWTX Edgewise Therapeutics, Inc. Mar 2, 2023 0 $0 3 Mar 7, 2023 Director